Developing a global P&MA strategy is a fundamental step in a global commercial drug launch; but a key challenge lies in then implementing the P&MA strategy at the local level in a consistent and effective way, which is crucial for success. However, upon the filing and launch stages, many young and established pharmaceutical companies struggle to ensure that all the local markets are optimally and individually prepared for launch.
Our recent webinar covered the important findings of a recent industry study conducted by Simon-Kucher. The study involved senior executives from pharmaceutical organizations of different sizes, and we explored the practical implications of these findings.
- Why Global-to-Local P&MA strategy activation is critical: Understand why biopharmaceutical launches often lag behind expectations (despite having a clear P&MA strategy in place), and the key role of local implementation
- Key P&MA launch activities and processes: Show the current status of launch preparations, and enhance transparency by outlining the typical interactions between different levels of the organization before a P&MA launch.
- Main challenges: Understand where the frequent shortcomings lie, and how to overcome them
- Key success factors: Master how to ensure local teams are optimally prepared to roll out the P&MA strategy
- Key recommendations: Learn the best-practices to drive P&MA launch readiness in the most effective and (time-)efficient ways
- Simon-Kucher’s LEAP: Get to know our program for an integrated, customizable launch readiness approach
Sessions were held in April 2024.
Watch our webinar on demand and dare to rethink your Global-to-Local P&MA strategy activation to empower your local affiliates upon the last mile of commercialization, and ultimately achieve your targeted P&MA outcomes.
Reach out to our team for more information!
